World Journal of Oncology, ISSN 1920-4531 print, 1920-454X online, Open Access
Article copyright, the authors; Journal compilation copyright, World J Oncol and Elmer Press Inc
Journal website

Original Article

Volume 4, Number 3, June 2013, pages 147-150

Treatment of Active Mucositis With Caphosol (Calcium Phosphate): A Retrospective Case-Series


Table 1. The Chemotherapy Regimens and Other Parameters
Age (Yrs)DiagnosisChemotherapyWorst Grade InitialGrade - Post TreatmentDuration of Treatment (Days)Frequency X/Day
TC: Taxotere and Cyclophosphamide, AC: Adriamycin and Cyclophosphamide, Doc: Docetaxel (Taxotere), FEC-D: 5 Flourouracil, Epirubicin and Cyclophosphamide-Taxotere, AC/T: Adriamycin, Cyclophosphamide and Paclitaxel, CMF: Cyclophosphamide, Methotrexate and 5 Flourouracil, ECF: Epirubicin, Cisplatin and 5 Flourouracil, Cis + Gem: Cisplatin and Gemcitibine.
1. 72Non-Small Cell Lung CaCarboplatin + Vinblastine2014
2. 54Breast CaTC3054
3. 50Breast CaAC x 4
Doc x 4 Herceptin
4. 57Breast CaFEC-D2022
5. 68Breast CaAC/T Dose dense2054
6. 76Breast CaFEC-D3032
7. 47Breast CaTC2024
8. 67Breast CaCMF1154
9. 51Breast CaAC/T Dose dense Herceptin2274
10. 50Breast CaAC/T Dose dense2022
11. 67Esophageal CaECF3054
12. 59Breast CaWeekly Doc2033
13. 45Breast CaCapecitibine3074
14. 70Breast CaFEC-D2132
15. 53Breast CaFEC-D2063
16. 64Breast CaFEC-D2074
17. 60Breast CaCis + Gem2054
18. 40Breast CaFEC-D2034
19. 59Breast CaFEC-D2054
20. 63Breast CaTC2034
21. 57Breast CaFEC-D2044